White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years

This publication has 16 references indexed in Scilit:

• Effectiveness of leukapheresis on early survival in acute myeloid leukemia: An observational propensity score matching cohort study
  Journal of Clinical Apheresis, 2023
• Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter study
  Leukemia & Lymphoma, 2022
• Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study
  Leukemia, 2020
• The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
  Leukemia, 2017
• Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
  Blood, 2016
• Genomic Classification and Prognosis in Acute Myeloid Leukemia
  New England Journal of Medicine, 2016
• Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis
  Leukemia Research, 2014
• Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia
  Current Opinion in Oncology, 2008
• Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
  Blood, 2002
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958